Eugenics Is Still a Dangerous Idea
By Dorothy Roberts,
The Inquirer
| 05. 01. 2019
At the turn of the 20th century, U.S. scientists proposed the control of reproduction to advance society based on the idea that genes determine individuals’ socially relevant traits. In 1910, prominent biologist Charles Davenport defined this project, known as eugenics, as “the science of human improvement by better breeding.” The false claim that scientists can isolate, test for, and quantify inherited characteristics that determine success in an unequal society was essential to eugenicists’ theory that social inequality comes from biology.
Eugenicists’ ideas found fertile ground in America, where they provided a scientific framework to justify the efforts of U.S. elites to preserve the unjust social order they had violently erected in prior centuries. That legacy has spanned decades into the present day.
One of the most widespread and devastating eugenicist weapons has been state-imposed sterilization to rid society of “socially inadequate” members. In March 1924, Virginia lawmakers passed a law that authorized the forced sterilization of people confined to government asylums because they were deemed “feebleminded.” In the 1927 case Buck v. Bell, Justice Oliver Wendell Holmes upheld...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...